Search clinical trials for: Budesonide + Azelastine

Total 600 results

Brigham and Women's Hospital
Massachusetts General Hospital; Baim Institute for Clinical Research

Terminated

The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations (GABLE)

Asthma

United States
Guangzhou Institute of Respiratory Disease

Completed

AMP-BPT and His-BPT for Assessment of Asthma (AMPHis)

Asthma
AstraZeneca

Completed

Budesonide / Formoterol in Treatment of Exacerbations of COPD

Chronic Obstructive Pulmonary Disease

Netherlands
AstraZeneca

Completed

Symbicort Onset of Action 2

Asthma
AstraZeneca

Completed

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Asthma

Germany
Norwegian University of Science and Technology
AstraZeneca

Terminated

Treatment of Microscopic Colitis

Colitis

Norway
East Carolina University

Unknown

Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.

Bronchopulmonary Dysplasia

United States
AstraZeneca

Recruiting

A 24-Week Efficacy and Safety Study to Assess Budesonide and Formoterol Fumarate Metered Dose Inhaler in Adult and Adolescent Participants With Inadequately Controlled Asthma (VATHOS) (VATHOS)

Asthma

United States, Canada, Italy, Japan, Vietnam, Spain, Germany, Malaysia
Amanda Stapleton

Terminated

Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19

Covid19 | Anosmia | Dysosmia

United States
University Hospitals Cleveland Medical Center

Completed

Cycling of Topical Steroids for Treatment of EoE (Eosinopilic Esophagitis)

Eosinophilic Esophagitis

United States
Genuine Research Center, Egypt
Hikma Pharmaceuticals LLC

Completed

Bioequivalence Study of Budesonide From Ekmasonid 9 mg Extended Release FCT (Hikma Pharma, Egypt) Versus Uceris 9 mg Extended Release Tablets (Man. for: Salix Pharm., a Division of Valeant Pharm. LLC, USA, by: Cosmo S.P.A., Italy by License of Cosmo Tech. Ltd., Ireland, Product of France)

Healthy

Egypt
University Hospital, Bordeaux

Withdrawn

Description of the Ability to Learn How to Handle Inhaler Devices in Asthma (AUDIT)

Asthma

France
University of Alberta
GlaxoSmithKline

Terminated

Asthma/Steroid Withdrawal Study

Asthma

Canada
Ligand Pharmaceuticals

Completed

Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of AR

Seasonal Allergic Rhinitis

Canada
Marinomed Biotech AG

Completed

Demonstration of Equivalence and Early Onset of a Novel Anti-allergic Nasal Spray Compared to Marketed Nasal Spray

Allergic Rhinitis | Allergic Conjunctivitis | Hayfever

Austria
Medical University of Lodz

Completed

Effect of Different Doses of Budesonide on Markers of Bone Metabolism in Children With Asthma

Asthma

Poland
Pearl Therapeutics, Inc.

Completed

A Randomized, Double-Blind, Parallel-Group, 24-Week, Chronic-Dosing, Multi-Center Study to Assess the Efficacy and Safety of PT010, PT003, and PT009 Compared With Symbicort® Turbuhaler® (Kronos) (KRONOS)

COPD

United States, Canada, China, Japan
Hospital Central "Dr. Ignacio Morones Prieto"
Universidad Autonoma de San Luis Potosí

Unknown

Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.

Respiratory Distress Syndrome | Bronchopulmonary Dysplasia | Infant,Premature

Mexico
St. Paul's Hospital, Canada

Unknown

Assessing Improvement in Cognitive Deficit in CRS in Patients Treated With Medical Vs Surgical Management

Chronic Sinusitis

Canada
AstraZeneca

Completed

A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS)

Relative Bioavailability

United States
AstraZeneca

Recruiting

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) (KALOS)

Asthma

United States, Canada, Denmark, Hungary, New Zealand, Poland, Spain, Korea, Republic of, Philippines, Italy, Argentina, Bulgaria, India, Japan, Vietnam, Taiwan, Thailand, Peru, Chile, Puerto Rico, Belgium, Australia, Netherlands, Romania
Kafrelsheikh University

Completed

The Role of Budesonide Intrapolyp Injection in the Management of Type 2 Chronic Rhinosinusitis

Chronic Rhinosinusitis With Nasal Polyps

Egypt
Washington University School of Medicine

Withdrawn

Coronavirus Smell Therapy for Anosmia Recovery (Co-STAR)

Anosmia

United States
King Saud University
King Fahad Medical City

Completed

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room

Status Asthmaticus

Saudi Arabia
Calliditas Therapeutics AB
Archimedes Development Ltd

Completed

Oral Treatment With PL-56 in Patients With IgA Nephropathy - an Explorative Study

IGA Nephropathy

Sweden
Pearl Therapeutics, Inc.

Completed

Pharmacokinetics and Safety Study of PT010 and PT003 in Healthy Chinese Adult Subjects

Chronic Obstructive Pulmonary Disease

China
Liaoning University of Traditional Chinese Medicine
Anshan Central Hospital; Shenyang Huanggu District Central Hospital; Benxi City...

Completed

Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.

Bronchial Asthma
Maisonneuve-Rosemont Hospital
The Canadian Blood and Marrow Transplant Group

Terminated

Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant

Respiratory Tract Infections | Lung Diseases, Interstitial | Bronchiolitis Obliterans | Cryptogenic Organizing Pneumonia

Canada
Johns Hopkins Bloomberg School of Public Health
National Heart, Lung, and Blood Institute (NHLBI); CAMP Steering Committee

Completed

Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) (CAMP)

Lung Diseases | Asthma
University of Michigan
Food and Drug Administration (FDA)

Recruiting

Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

Human Gastrointestinal Physiology Data

United States
AstraZeneca

Recruiting

A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD

COPD (Chronic Obstructive Pulmonary Disease)

United States, Turkey, Vietnam, Malaysia, Philippines, Thailand, Hungary, Mexico, Korea, Republic of, Argentina, Canada, India, Bulgaria, Poland
Orion Corporation, Orion Pharma

Completed

Use of Buventol Easyhaler and Bufomix Easyhaler in Methacoline Challenge Testing (EASYRELIEF)

Asthma

Finland
Zhujiang Hospital

Unknown

Assessment of Airway Responsiveness and Treatment Efficacy in Asthmatics

Asthma

China
Bond Avillion 2 Development LP

Completed

To Compare the Pharmacokinetics of Budesonide Delivered by BDA MDI to Budesonide Delivered by Pulmicort Respules in Children With Asthma Aged 4 to 8 Years. (BLANC)

Asthma

United States
Dr. Falk Pharma GmbH

Completed

Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis

Lymphocytic Colitis

Germany
Hospital Israelita Albert Einstein
Hospital M'Boi Mirim

Unknown

Comparison Between Budesonide and Dexamethasone Treatments for Respiratory Discomfort After Extubation on Children (BUDEXA)

Stridor

Brazil
St. Paul's Hospital, Canada

Withdrawn

Efficacy of Budesonide Via Delayed Release vs Immediate Release

Chronic Rhinosinusitis (Diagnosis)
St. Paul's Hospital, Canada

Unknown

Comparing Budesonide Via MAD or INSI Prospective Cohort Study

Chronic Rhinosinusitis With Nasal Polyps | Allergic Fungal Sinusitis
Pierre Fabre Medicament

Completed

Emollients in the Management of Atopic Dermatitis

Atopic Dermatitis

France, Romania, Estonia, Poland, Lithuania
Dr. Falk Pharma GmbH

Completed

Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis

Collagenous Colitis

Germany
Novartis Pharmaceuticals

Completed

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

COPD

China
Queen Mary University of London

Completed

Therapeutic Approaches to Malnutrition Enteropathy (TAME)

Severe Acute Malnutrition

Zimbabwe, Zambia
University of Vermont Medical Center

Completed

The Efficacy of MEDIHONEY® for Chronic Rhinosinusitis With Nasal Polyposis After Functional Endoscopic Sinus Surgery

Chronic Sinusitis | Nasal Polyposis

United States
Intech Biopharm Ltd.

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block

Asthma | Chronic Obstructive Pulmonary Disease (COPD)
Kuopio University Hospital

Completed

Stepping Down of Asthma Medication in Controlled Asthma

Asthma

Finland
Mayo Clinic
AstraZeneca

Completed

The Role Of Gastroesophageal Reflux Disease (GERD) in Eosinophilic Esophagitis

Gastroesophageal Reflux Disease | GERD | Eosinophilic Esophagitis | EE

United States
AstraZeneca

Completed

Rhinocort Aqua Versus Placebo and Fluticasone Propionate

Seasonal Allergic Rhinitis
Puma Biotechnology, Inc.

Completed

An Open-Label Study to Characterize the Incidence and Severity of Diarrhea in Patients With Early-Stage HER2+ Breast Cancer Treated With Neratinib and Loperamide

Early Stage HER2+ Breast Cancer

Spain, United States, France, Australia, Germany, Austria, Canada
Intech Biopharm Ltd.

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block

Asthma | COPD

Taiwan
Intech Biopharm Ltd.

Completed

Bioavailability Study of SYN006, Pulmicort pMDI and Meptin Air in Healthy Adult.

Asthma | Chronic Obstructive Pulmonary Disease (COPD)

Taiwan

3

Subscribe